Send me a link:

*Text messaging rates may apply.

 Dow Down0.32% Nasdaq Up0.31%

Imprimis Pharmaceuticals, Inc. (IMMY)

-NasdaqCM
7.30 Up 0.15(2.10%) 1:42PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 10   100   -  
Cost of Revenue -   -   -  
Gross Profit 10   100   -  
Operating Expenses
Research Development1,616  1,299  112  
Selling General and Administrative6,081  2,980  828  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (7,687) (4,179) (939)
Income from Continuing Operations
Total Other Income/Expenses Net44  (1,180)60  
Earnings Before Interest And Taxes(7,643)(4,163)(879)
Interest Expense -  25  75  
Income Before Tax(7,643)(4,188)(954)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(7,643)(5,384)(894)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (7,643) (5,384) (954)
Preferred Stock And Other Adjustments -  (200)(100)
Net Income Applicable To Common Shares (7,643) (5,584) (1,054)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.